RADAR: A Randomized Discontinuation Phase II Study to Determine the Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer; Bone metastases
- Focus Therapeutic Use
- Acronyms RADAR
- 01 Dec 2013 Results published in the Journal of Cancer Research and Clinical Oncology.
- 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 24 Mar 2012 Results presented at the 8th European Breast Cancer Conference.